EUVIMEDEUVIMED entdecken
Crossref

N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells

Yi Wu, Yongtai Wu, Zhenhui Zhang, Jiaxian Cai, Minhua Zong, Lin Li, Xia Zhang, Hong Wu, Bing Li

ACS Food Science & Technology · 20.10.2023 · 3 (10) · 1635-1645

DOI: 10.1021/acsfoodscitech.3c00176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Food Science & Technology, online erschienen am 09.09.2023. Verfasst von Yi Wu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced glycation end products (AGEs) are widely found in processed foods; their free fractions could significantly affect cellular glucose and lipid metabolism, but this mechanism remains poorly understood. We selected N ε -(carboxymethyl)lysine (CML) as a representative free AGE to study the biochemical processes involved in glucose metabolism, lipid synthesis, and catabolism in human LO2 cells. A combination of biochemical, metabolic flux, and comparative experiments revealed that the mechanism of CML intervention in glucose metabolism mainly involves promoting the dephosphorylation of glucose 6-phosphate and inhibiting the conversion of cis -aconitate to isocitrate in the Krebs cycle. Regarding lipid metabolism, CML combined with high-glucose stimulation synergistically promoted de novo lipogenesis, and CML also promoted fatty acid β-oxidation. These results provide constructive insights into the mechanisms and targets of the imbalance in cellular glucose and lipid metabolism induced by dietary AGEs.

Förderung

  • Guangzhou Municipal Science and Technology Bureau

Zitieren

APA

Wu, Y., Wu, Y., Zhang, Z., Cai, J., Zong, M., Li, L., Zhang, X., Wu, H., & Li, B. (2023). N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells. ACS Food Science & Technology, 3(10), 1635-1645. https://doi.org/10.1021/acsfoodscitech.3c00176

Vancouver

Wu Y, Wu Y, Zhang Z, Cai J, Zong M, Li L, et al. N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells. ACS Food Science & Technology. 2023;3(10):1635-1645. doi:10.1021/acsfoodscitech.3c00176

BibTeX
@article{Wu2023,
  author = {Wu, Yi and Wu, Yongtai and Zhang, Zhenhui and Cai, Jiaxian and Zong, Minhua and Li, Lin and Zhang, Xia and Wu, Hong and Li, Bing},
  title = {N ε -(Carboxymethyl)lysine (CML) Promotes Disorders of Glucose and Lipid Metabolism in Human Hepatic LO2 Cells},
  journal = {ACS Food Science & Technology},
  year = {2023},
  volume = {3},
  number = {10},
  pages = {1635--1645},
  doi = {10.1021/acsfoodscitech.3c00176}
}
Kostenlos starten →